Received Apr 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 7+ | B0005 | IM / LA |
| FLU3 | INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) | SANOFI PASTEUR | N/A | UT8454CA | IM / RA |
No adverse event reported. Reporting this VAERS per Moderna after a temperature excursion, vaccine remained viable after the excursion per Moderna.
bilateral foot pain, lower back pain
type 2 DM, hypertrophic obstructive cardiomyopathy, essential hypertension, automatic cardiac defribrillator, hypertrophic cardiomyopathy, severe left ventricular hypertrophy, osteoarthritis of both knees, unilateral vestibular schwannoma, radiculopathy of lumbar region, orthostatic dizziness, benign paroxysmal positional vertigo, bilateral floaters, mixed conductive and sensorineural hearing loss of right ear, unspecified open-angle glaucoma, atypical serocystic neoplasm pancreas tail, adenocarcinoma of prostate, renal mass, chronic kidney disease stage 3, lower urinary tract symptoms, cannabis use disorder, cocaine use disorder, adjustment disorder, erectile dysfunction, hyperlipidemia, edema
ondansetron HCL, finasteride, basaglar insulin, albuterol HFA, aspirin, atorvastatin, entresto, furosemide, jardiance, latanoprost, metformin XR, metoprolol succinate XL, nortriptyline, potassium chloride, spironolactone, tamsulosin, betaxo
morphine, atenolol, ibuprofen, sulfamethoxazole-trimethoprim
N/A